A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751

NCT01981694 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer